Cytokinetics, Incorporated
Sharon A. Barbari,
EVP, Finance and Chief Financial Officer
Robert I. Blum,
President & Chief Executive Officer
David W. Cragg,
SVP, Human Resources
Fady I. Malik, MD, PhD, FACC,
SVP, Research and Early Development
Bradley P. Morgan, PhD,
VP, Drug Discovery & Early Development
Elisabeth A. Schnieders, PhD,
VP, Business Development
Marjorie C. Wagman, JD,
VP, Legal Affairs
Andrew A. Wolff, M.D., FACC
SVP, Clinical Research and Development, and Chief Medical Officer
Robert I. Blum,
Cytokinetics, Inc.
Santo J. Costa,
Of Counsel,
Smith, Anderson, Blount,
Dorsett, Mitchell and Jernigan, L.L.P
Steve Dow,
Sevin Rosen Funds
L. Patrick Gage, Ph.D. (Chairman),
Industry Consultant
Denise M. Gilbert, Ph.D.,
Industry Consultant
John T. Henderson, M.D.,
Industry Consultant
B. Lynne Parshall, Esq,
Isis Pharmaceuticals, Inc.
Sandford D. Smith,
Tullis Health Investors
Wendell Wierenga, Ph.D.,
EVP, R&D, Santarus, Inc.